La larga espera por la cura de la diabetes
Un documental recoge la desesperación y la frustración de los pacientes de diabetes de tipo 1 que participan en un ensayo clínico.
Un documental recoge la desesperación y la frustración de los pacientes de diabetes de tipo 1 que participan en un ensayo clínico.
What You Should Know: – Health insurer UnitedHealthcare has donated $11M in grants to nonprofit organizations across 11 states. – These grants are part of […]
Cost of the life-saving drug will remain many times higher than in other affluent countries after Republicans defeated the measure During the Covid-19 pandemic, Erin […]
Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.
The most well-published community-based lifestyle intervention in the medical literature is also one of the most effective. CHIP, the Complete Health Improvement Program—now known as […]
What You Should Know: – Teladoc Health recently added an at-home A1C testing program to its chronic care solution, making it easier for members to manage their diabetes while also bridging health […]
Starting in 2025, Medicare recipients with prescription drug coverage will not have to pay more than $2,000 annually for medications, a significant savings for some.
What You Should Know: – Vision Loss Rehabilitation Canada (VLRC) and Eyenuk, Inc. launches of VLRC’s Eye Health Screening Initiative to screen rural, remote and […]
The CHIP program (now called Pivio) has attempted to take the pioneering lifestyle medicine work of Pritikin and Ornish and spread it out into the […]
A documentary captures the desperation and frustration of Type 1 diabetes patients in a clinical trial.
Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his […]
Elizabeth Hogan Hamacher, MHL, BSN, RN, VP of Clinical Services and Support, Podimetrics Diabetes is one of the most common chronic diseases in the United […]
What You Should Know: – One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, announced outcomes from […]
RxBenefits, a pharmacy benefits optimizer, and Tria Health, a chronic condition and medication management company, have launched a new partnership to improve diabetes care and […]
A half-teaspoon a day of brewer’s yeast is put to the test in a randomized, double-blind, controlled clinical trial. In 1854, a case report was […]
The rising levels of both type 1 and type 2 diabetes in American youth is quickly becoming a major public health concern. To help address […]
Five GOP senators are calling on the Senate Finance Committee to hold hearings on bipartisan legislation to lower the cost of insulin. Led by Sens. […]
Recent advancements in AI have demonstrated that AI can accurately detect diabetes through the analysis of retinal images that retina experts would consider healthy. To […]
David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type […]
Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets. Health2Sync […]
Sen. Susan Collins (R-Maine) is facing an uphill climb as she seeks to win over GOP colleagues for a bipartisan insulin bill ahead of a […]
Almost half of older adults — more than 26 million people 65 and older — have prediabetes, according to the Centers for Disease Control and […]
Dr. Melissa Lim, Chief Medical Officer at Somnology Getting a good night’s sleep should have nothing to do with having a great health plan — […]
Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new device that will measure both glucose and […]
SACRAMENTO — California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic […]
Non-communicable diseases (NCDs) are on the rise in low- and middle-income countries (LMICs), increasing the financial and health burden affecting these vulnerable populations. To reverse […]
VICTORVILLE, Calif. — Every Friday, Frances De Los Santos waits for a shipment of healthy, prepared meals to land on her front porch at the […]
Many insurance companies refuse to cover new weight loss drugs that their doctors deem medically necessary.
Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check. […]
The FDA approved Eli Lily drug Mounjaro as a treatment for type 2 diabetes. The decision gives the pharmaceutical giant a new competitor to a […]
What You Should Know: – In an effort to make blood glucose data more actionable for providers and patients alike, Rimidi, a leading clinical management […]
For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying […]
Chicken, fish, and egg powder in processed foods present greater risk from cholesterol oxidation byproducts, but there are things you can do to reduce exposure. […]
Abbott has joined forces with two other companies to bring an automated insulin delivery (AID) system to people with diabetes in Europe that will monitor […]
KHN Midwest correspondent Bram Sable-Smith shared a firsthand perspective on ballooning insulin costs on “Tradeoffs” on April 21. Click here to hear Sable-Smith on “Tradeoffs” […]
“The price of insulin increases as waistlines increase.” Rep. Matt Gaetz on Twitter, March 31, 2022 At the end of March, after the House passed […]
Tom Zaubler, MD, Chief Medical Officer of NeuroFlow Since the passage of the Medicare Improvements for Patients & Providers Act in 2008, the U.S. healthcare […]
The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. […]
KHN Midwest correspondent Bram Sable-Smith discussed insulin costs on NBC’s LX on April 6. Click here to watch Sable-Smith on LX Read Sable-Smith’s “I Write […]
Mark Clements, MD, PhD, CPI, FAAP, Chief Medical Officer, Glooko, Inc. If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding […]
The chances of passing election-year legislation to help people afford insulin — which weeks ago seemed mired in political fighting — are looking brighter as […]
The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton […]
The bill stands to benefit millions of Americans with diabetes, but to become law, it will need to attract at least 10 Republican votes in […]
More than 250,000 people living with type 1 diabetes in the UK will be offered real-time continuous glucose monitoring (CGM) technology, reducing their reliance on […]
What You Should Know: – Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized […]
What You Should Know: – Podimetrics raises $45M to help at-risk providers and health plans prevent diabetic amputations in high-risk patients. – With this latest […]
What You Should Know: – 9am.health today announced it is expanding its virtual diabetes clinic through a strategic partnership with Ascensia to add the CONTOUR®NEXT ONE Blood Glucose […]
The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the monthly cost of insulin to patients that […]
David Maahs, MD, Division Chief of Pediatric Endocrinology, Stanford Children’s Health A recent study from Stanford found that pediatric patients with rapid access to continuous […]
Researchers in Germany are have found a possible link between mild COVID-19 infection and an increased risk of type 2 diabetes, although they caution the […]
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient […]
Better Therapeutics reported that its digital therapeutic for type 2 diabetes met the main goal of a pivotal study. An FDA submission is expected in […]
The latest version of Abbott’s FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott’s […]
Heather Korbulic, Senior Policy and Strategy Lead, GetInsured The COVID-19 pandemic led to sweeping healthcare policy changes that enable vulnerable Americans to receive affordable health coverage and access […]
Democrats in the Senate are primed this month to make their first attempt at salvaging one of the most popular elements of President Joe Biden’s […]
Civica Rx plans to make lower cost versions of three branded insulin products, biosimilars that are expected to reach the market in 2024. In addition […]
President Joe Biden argued forcefully for the power of democracy while calling out Russia’s invasion of Ukraine in a March 1 State of the Union […]
What You Should Know: – CVS Health released their Drug Trend Report, examining the drivers of overall and specialty drug trend through the first three quarters of 2021. Data were calculated on a […]
What You Should Know: – Omada Health, a chronic care integrated healthcare provider, today announced its $192M in Series E funding round led by Fidelity […]
Omada got funds from two new investors – Fidelity Management & Research Company and aMoon as well as existing ones. Verily’s Onduo is bringing its […]
Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries […]
What You Should Know: – EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and […]
What You Should Know: – Teladoc Health, today announced the launch of Chronic Care Complete, a first-of-its-kind chronic condition management solution to help individuals improve their […]
Jonathan Bingham – Janeiro Digital, CEO Interoperable data and IT systems in healthcare has long been an enigma – many have tried to tackle the […]
What You Should Know: – VillageMD announced it has acquired Healthy Interactions, which helps patients manage chronic conditions through interactive educational programming as part of […]
Nothing brightens our Twitter feeds like a few good health policy valentines ― except maybe a haiku or two. Tweeters showered us with love this […]
Digital health company Glooko acquired Germany-based company xbird, a medical AI company with JITAI (Just In Time Adaptive Intervention) technologies to predict patient behavior and […]
Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients, and has now added artificial intelligence […]
I got a hurried voicemail from my pharmacist in Wisconsin the day before Thanksgiving letting me know my insurance was refusing to cover my insulin. […]
The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded […]
President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.
President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, […]
In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics. Francine Kaufman […]
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
By JESSICA DaMASSA, WTF Health To hear Vida Health’s CEO Stephanie Tilenius talk about what she’s hearing from payers, providers, and employers about at-risk value-based […]
Its vast experience in diabetes and the amount of data collected has propelled Novo Nordisk into exploring new modalities and searching for valuable collaborators, according […]
Shots: The companies launch Semglee and Insulin Glargine as interchangeable biosimilars products to improve patients’ access with type 1 & 2 diabetes. Biocon and Viatris […]
(World Diabetes Day, 14 November 2021) Largest tooth loss research study finds poor glycemic control in the over 30s results in fewer teeth In the […]
What You Should Know: – DreaMed Diabetes AI, developer of the AI-powered Advisor Pro Clinical Decision Support System and expert-care platform for diabetes, announced today […]
Better Therapeutics has joined the ranks of publicly-listed digital health companies after completing a merger with blank cheque company Mountain Crest Acquisition Corp II. The […]
By all accounts, Ro is a successful direct-to-consumer telehealth and pharmacy services startup. At the recently-concluded HLTH conference, Ro’s chief medical officer speculated on how […]
The company, which offers an AI platform that provides personalized health coaching for chronic disease patients, will use the new funds to invest in research […]
The developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases like diabetes to help model the impact […]
The company recently published new results on its MOBILE study, which found that CGM use increased time in range for people with Type 2 diabetes. […]
In an interview with PharmaShots, Dr. David Kendall, Senior Global Medical Advisor at Zealand Pharma shares insight on the availability of Zegalogue in the US […]
Frank Westermann sold his previous startup, mySugr, to Roche four years ago. Now, he’s starting a new company with the goal of making healthcare providers […]
What You Should Know: – 9am.health, a new San Diego, CA-based virtual diabetes clinic delivering personalized, affordable and kind care directly to consumers, today announced […]
What does a review of the evidence on the effects of coconut oil on weight loss and belly fat find? I begin my video Flashback Friday: Coconut Oil and Abdominal Fat with a popular infographic that […]
After a decade of living with chronic kidney disease, Vonita McGee knows her body is wearing out. At 63, McGee undergoes dialysis sessions three times […]
Digital health startup Breathe Well-being has raised $5.5 million in first-round financing, which it will use to scale up its clinical tool that it says […]
College is a time of transition, but for those managing chronic medical conditions, it may also be the first time they will be wholly responsible […]
As per the WHO, “the number of people affected with Diabetes has grown significantly from 108 million in 1980 to 422 million in 2014. A […]
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They […]
The Patient-Centered Outcomes Research Institute has awarded the funds to studies that span a range of healthcare issues, including maternal care, suicide prevention and clinical […]
Shots: The US FDA has approved Semglee (insulin glargine-yfgn injection) as the first interchangeable biosimilar product under the 351(k) regulatory pathways to treat diabetes Semglee […]
Damon Diessner tried for years to slim down from his weight of more than 400 pounds, partly because his size embarrassed his wife but even […]
Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a […]
Eli Lilly has Protomer Technologies, a preclinical startup developing next-generation insulin that senses blood glucose levels and adjusts its activity accordingly. The technology could eliminate […]
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the […]
Bayer’s big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA […]
The FDA indicated something was not well with Provention Bio’s filing for type 1 diabetes therapy teplizumab in April when it delayed its review. Now, […]
Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.
Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.
Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.
US healthcare group Carbon Health has made a move into digital care for patients with chronic conditions, buying diabetes-focused startup Steady Health. Steady Health has […]
Chemist who transformed medical screening by developing glucose dipsticks In the 1950s the US chemist Helen Murray Free, who has died aged 98, was responsible […]
Shots: EMDAC has voted 10-7, confirming that the benefits of teplizumab outweigh the risks supporting the approval to delay T1D Mellitus The recommendation is based […]
Eli Lilly has scored five out of five with its phase 3 trials of type 2 diabetes candidate tirzepatide, setting up regulatory filings for a […]
Eli Lilly diabetes drug tirzepatide beat long-acting insulin in the last of a series of global studies designed to support regulatory submissions for the type […]
UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other […]
Are the apparently amazing benefits of amla—dried Indian gooseberries—too good to be true? In reference to amla, also known as the Indian gooseberry, it’s been […]
The startup received 510(k) clearance for its “smart” insulin pen cap, which pulls in data from users’ connected glucose monitor to help them calculate the […]
Olivia Klassen’s face lights up when she talks about summer camp. She loves to do the scavenger hunt with her camp friends. She also loves […]
Becton Dickinson is known worldwide for its diabetes products. Now the medical technologies giant plans to spin off its diabetes care business as a separate, […]
Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral […]
Conventional wisdom would hold that the prices are rising…aren’t they? To correctly answer this question, one must define which prices you are talking about. Are […]
After an indifferent period Novo Nordisk has kicked off 2021 on the front foot, raising its financial forecast after posting better than expected Q1 earnings […]
In an interview with PharmaShots, Emmanuel Dulac, Pharm.D., Ph.D., President and CEO of Zealand Pharma shares insight on the US FDA’s approval of Zegalogue and its […]
Virta Health, a digital health startup with an app-based coaching program for type 2 diabetes, raised $133 million led by Tiger Global. Unlike other digital health […]
The Blue Cross Blue Shield Association recently announced its new national health equity strategy that will focus on maternal health, diabetes, cardiovascular care and mental […]
What You Should Know: – Virta Health, a San Francisco, CA-based company raises $133M led by , to scale its virtual metabolic clinic and approach […]
Shots: The company has launched the first virtual clinic to guide patients with chronic conditions and helps to improve health and behavior via tracking tools […]
What are the risks and benefits of getting an annual check-up from your doctor? Physicians and patients have come to expect the annual check-up as […]
Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 […]
What You Should Know: – Medtronic has announced the launch of the world’s first and only infusion set that can be worn for up to […]
Shots: The companies launched the Mallya smart insulin pen device in France to support patients with diabetes. The smart insulin pen is available in pharmacies […]
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Glucose […]
What You Should Know: – Blue Shield of California is enhancing its popular Wellvolution program by adding two new services that provide personalized care and […]
Birju Shah, Head of Product for Uber Health & Communities Nick Jordan, Founder and CEO, Narrative In a world where technology and Big Data can provide […]
When it comes to Diabetes, there are atleast dozens of different advices you can expect from different people. Don’t eat sweets, carbs are bad for […]
When it comes to reversing diabetes, let’s clear that out that its Diabetes Type 2 that is reversible and not Type 1. But what makes […]
Mark Prather MD, MBA, CEO & Co-founder at DispatchHealth The COVID-19 pandemic has transformed how we interact with one another, with businesses, and with the […]
Shots: The approval is based on efficacy results from P-III studies involve assessing Zegalogue vs PBO in children aged 6-17yrs. and in adults with T1D […]
Venky Ananth, SVP, Global Head of Healthcare at Infosys The healthcare industry has been among those at the fore when it comes to cloud adoption. […]
What You Should Know: – Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today […]
What happened when turmeric curcumin was put to the test to see if it could reverse DNA damage caused by arsenic exposure? Arsenic is a […]
In the nation’s battle against the diabetes epidemic, the go-to weapon being aggressively promoted to patients is as small as a quarter and worn on […]
A primer on what sugar does in your body and ways to avoid the negative effects of excess sugar.
How should we properly cook beans? In the 1800s, a compound was discovered in castor beans, which we would come to know as the first […]
Shots: Biolojic to receive ~$121M including development and commercialization milestones and a promissory note that may be convertible into Biolojic equity in future Additionally, Biolojic […]
Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program […]
A book purported to expose “hidden dangers” in healthy foods doesn’t even pass the whiff test. I started getting emails about The Plant Paradox, a […]
Athar Siddiqui: Global Strategy Lead, Digital Connected Solutions – Ascensia Diabetes Care “Information technology and business are becoming inextricably interwoven. I don’t think anybody can […]
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
What You Should Know: – Verily’s Onduo, known for its tech-based solution for virtual diabetes management, is launching a new multi-condition platform that matches the right care to […]
Bryan Lubel, Executive Vice President, Connected Health of KORE Not many will disagree that the global pandemic has accelerated the use of technology in healthcare. […]
What You Should Know: – DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on […]
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. In […]
The Senate Finance Committee has released a new report detailing findings of their investigation into the role that market dynamics play in the pricing of […]
Are there unique benefits to brown rice that would justify keeping it in our diet despite the arsenic content? For years, warnings had been given […]
Travis Dalton Dan Devers Cerner announced some leadership changes promoting long-time associates Travis Dalton to Chief Client & Services Officer and Dan Devers to Chief Legal Counsel. After […]
What You Should Know: – FCC announces initial 14 pilot project selected for $100M Connected Care Pilot Program that will support connected care service across […]
Arsenic is not just considered to be a carcinogen; it’s also designated as a “nonthreshold carcinogen, meaning that any dose, no matter how small, carries […]
What You Should Know: – Teladoc Health and Dexcom announced an expanded partnership on a new offering measures the impact of continuous glucose monitoring and […]
Two years after starting to work together, Novo Nordisk and Dicerna have selected the first candidate from a joint project to find new, gene-silencing drugs […]
Adam Sabloff, Founder and CEO of VirtualHealth As we re-examine the healthcare system in the wake of the pandemic, we are continually identifying opportunities to […]
Donovan Quill, President and CEO, Optime Care Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for […]
What You Should Know: – Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. – […]
What You Should Know: – The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. […]
What You Should Know: – Cerner Corporation today announced with Xealth new centralized digital ordering and monitoring for health systems, starting with Banner Health, to […]
What You Should Know: – Elation Health, which provides an easy-to-use and affordable clinical technology platform for more than 7 million independent primary care clinicians […]
Eli Lilly’s decision to throw large amounts of research dollars at its next-generation diabetes drug tirzepatide could be vindicated, according to its first phase 3 […]
A daily half-cup of cooked rice may carry a hundred times the acceptable cancer risk of arsenic. What about seaweed from the coast of Maine? […]
What You Should Know: – Highmark, one of the largest Blues plans, has chosen Lark Health for its chronic disease prevention and management platform. – […]
The expanded partnership increases the number of Highmark health plan members eligible for enrollment in Lark Health’s AI-driven health coaching programs aimed at managing and […]
Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose […]
Providing care for chronic disease patients during a one-in-a-century pandemic is full of challenges, but health systems like Jefferson Health are finding ways — with […]
Even at low-level exposure, arsenic is not just a class I carcinogen, but may also impair our immune function and increase our risk of cardiovascular […]
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. A validated program that can effectively help […]
First results of the DiabetRisk study – Over 8% of patients identified with undiagnosed diabetes or pre-diabetes at dental practices The DiabetRisk study could contribute […]
Jenifer Leaf Jaeger, MD, MPH, Senior Medical Director, HealthEC Senior isolation is a health risk that affects at least a quarter of seniors over 65. […]
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started […]
A new post-hoc analysis from Novo Nordisk of their SUSTAIN 6 and PIONEER 6 studies into semaglutide is looking to help ‘individualise’ treatment for diabetes […]
What You Should Know: – Omada’s diabetes prevention program will be available to Intermountain’s at-risk patient population as part of a limited engagement in 2020 […]
Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as […]
The post Don’t let COVID-19 defer the diabetes care you need appeared first on Healthy Debate.
As part of our series looking at how pharma companies have adapted to the pandemic, Shannon Rush, leader of Eli Lilly & Co’s diabetes business […]
Novo Nordisk has agreed to buy Emisphere Technologies for $1.8 billion, as it continues its quest to develop diabetes medicines that can be taken as […]
Matt Dickson, VP, Product, Strategy, and Communication Solutions at Stericycle COVID-19 terms such as quarantine, flatten the curve, social distance, and personal protective equipment (PPE) […]
Ram Sathia, VP of Intelligent Automation at PK While most of the public’s attention is focused on the horse race for an approved COVID-19 vaccine, […]
Lark Health, which offers AI-powered digital care platforms for chronic diseases, has raised $70 million in new funds, which it plans to use to expand […]
At the start of my video What Does a Low White Blood Cell Count Mean?, you can see what it looks like when you take […]
What You Should Know: – Doctor On Demand and CareLinx, one of the largest professional networks for in-home care, have announced a collaboration to bring […]
Eric Tran, Tulane School of Medicine Donald Voltz, MD, Aultman Hospital The COVID-19 virus is ravaging the planet at a scale not seen since the […]
What You Should Know: – Priority Health launches its virtual-first coverage option with MyPriority Telehealth PCP plans, using top platform Doctor On Demand. – Members […]
What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program […]
What You Should Know: – Today, Blue Cross and Blue Shield of North Carolina partners with Carrot Inc. and Virta Health to help address two […]
During the first presidential debate of 2020, President Donald Trump touted his efforts to curb skyrocketing drug prices and declared that insulin is […]
Shots: The companies will partner to promote Lyumjev (insulin lispro-aabc injection, 100 & 200 units/mL) with Dexcom G6 CGM to aid HCPs in the US […]
What You Should Know: – Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. – […]
DENVER — D.j. Mattern had her Type 1 diabetes under control until COVID’s economic upheaval cost her husband his hotel maintenance job and their health […]
What You Should Know: – NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several […]
Andy Aroditis, CEO, NextGate The COVID-19 pandemic is not just a medical crisis. Since the highly contagious disease hit American shores in early 2020, the […]
When food production technology made it possible, wheat flour processors started to eliminate the tough exterior (bran) and nutrient-rich core (germ) of the kernel to […]
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The […]
What You Should Know: – Validic launches the newest version of its remote patient monitoring (RPM) offerings, Validic Impact: Rapid Deployment. – This new standalone […]
Dr. Kayur Patel, Chief Medical Officer of Proactive MD The impact of the coronavirus crisis is shining a bright light on many of the challenges […]
UK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes spectrum manage their condition. The app – […]
Dr. Donald Brown, CEO and founder of LifeOmic The coronavirus pandemic has affected every aspect of our lives, from how we work to how we […]
What You Should Know: – Today, Medtronic announced that it will acquire Companion Medical, the manufacturer of InPen, a smart insulin pen system paired with an integrated […]
What You Should Know: – DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center […]
Denmark’s Novo Nordisk has beaten profit forecasts in the second quarter after overcoming tough conditions in the diabetes market by improving its productivity. Novo said […]
What You Should Know: – Innovaccer has recently partnered with CareSignal to address healthcare’s urgent need amidst the COVID-19 pandemic: to create and maintain solid, […]
– Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services […]
Abhinav Shashank, CEO and Co-founder of Innovaccer Inc. COVID-19 has presented healthcare with a challenge like no other, with nearly nine million cases all over the […]
Shots: The P-III EMPEROR Trial involves assessing of Jardiance (10 mg) vs PBO in two studies EMPEROR-Reduced [NCT03057977, N=3,730] & EMPEROR-Preserved [NCT03057951, N=5,990] in patients […]
Physical fitness authorities seem to have fallen into the same trap as the nutrition authorities, recommending what they think may be achievable, rather than simply […]
Medical device company Indigo Diabetes has raised 38 million euros to develop an “invisible” sensor for people with diabetes, which could provide an alternative to […]
AstraZeneca’s Farxiga could be on course for another use, after trial results showed it slowed the worsening of renal function and cut the risk of […]
What You Should Know: – Current Health has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM) platform […]
What You Should Know: – GoodRx today announced it has expanded the reach of HeyDoctor by GoodRx and it is now available across all 50 […]
Biocon has announced a deal with digital therapy specialist Voluntis, aiming to create personalised care for people with type 2 diabetes taking biosimilar insulins. The […]
What You Should Know: – Dario Health enters strategic partnership with Williams Medical marking its expansion into the UK remote patient monitoring market across the […]
Whole plant sources of sugar and fat can ameliorate some of the postprandial (after meal) inflammation caused by the consumption of refined carbohydrates and meat. […]
What You Should Know: – CVS introduced Spoken Rx™, a new feature of the CVS Pharmacy app that can read important prescription information out loud. It is […]
What You Should Know: – Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the hospital. […]
Do BPA-free plastics such as Tritan, have human hormone-disrupting effects? And what about BPS and BPF? Recent human studies indicate that exposure to the plastics […]
Cutting two teaspoons of salt’s worth of sodium from one’s daily diet can significantly improve lung function in asthmatics In the 1960s and 1970s, a […]
What’s more important: probiotics or prebiotics? And where can we best get them? “Virtually every day we are all confronted with the activity of our […]
The compelling finding of Mycobacterium avium paratuberculosis (MAP) circulating disproportionately within the bloodstream of type 1 diabetics was subsequently confirmed by culturing it straight out […]
Type 1 diabetes “arises following the autoimmune destruction of the insulin-producing pancreatic β [beta] cells…[and] is most often diagnosed in children and adolescents, usually presenting […]
Copyright © 2024 | WordPress Theme by MH Themes